跳至主要内容
临床试验/NCT04868916
NCT04868916已完成不适用

Prospective Observational Study to Estimate the Genotype and Phenotype of Japanese Patients With X-linked Retinitis Pigmentosa Associated With Pathogenic Variants in Retinitis Pigmentosa GTPase Regulator (RPGR)

Janssen Pharmaceutical K.K.1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2021年7月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Visual Function

研究概览

简要总结

The purpose of the study is to identify a cohort of Japanese participants with X-linked retinitis pigmentosa (XLRP) associated with pathogenic variants in the retinitis pigmentosa GTPase regulator (RPGR) gene and to investigate their associated phenotype.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
5 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have RPGR-associated retinal dystrophy
  • Are able to give informed consent or assent, with the guidance of their parent/guardian where appropriate
  • Are able to undertake age-appropriate clinical assessments as specified in the protocol

排除标准

  • Are unable or unwilling to undertake consent or clinical testing
  • Participated in another research study and had intraocular surgery within 3 months of screening
  • Significant ophthalmologic diseases

结局指标

主要结局

Visual Function

时间窗: Up to Day 30

Visual function will be assessed using visual acuity.

Retinal Structure

时间窗: Up to Day 30

Retinal structure will be assessed using spectral domain optical coherence tomography (SDOCT).

Retinal Function

时间窗: Up to Day 30

Retinal function will be assessed using static visual field testing.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验